Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FRES

Fresh2 Group (FRES) Stock Price, News & Analysis

About Fresh2 Group Stock (NASDAQ:FRES)

Advanced Chart

Key Stats

Today's Range
$0.85
$0.85
50-Day Range
$0.85
$1.38
52-Week Range
$0.73
$6.49
Volume
N/A
Average Volume
35,810 shs
Market Capitalization
$765,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Receive FRES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresh2 Group and its competitors with MarketBeat's FREE daily newsletter.

FRES Stock News Headlines

Elon’s 2025 Silver Crisis (What It Means for You)
Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.
Why Is Fresh2 Group (FRES) Stock Up 31% Today?
See More Headlines

FRES Stock Analysis - Frequently Asked Questions

Fresh2 Group shares reverse split on the morning of Wednesday, July 10th 2024. The 1-10 reverse split was announced on Wednesday, July 10th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresh2 Group investors own include Amgen (AMGN), Amprius Technologies (AMPX), Axon Enterprise (AXON), PACCAR (PCAR), Arch Capital Group (ACGL), Adobe (ADBE) and Analog Devices (ADI).

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:FRES
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.75 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
663,000
Market Cap
$765,000.00
Optionable
Not Optionable
Beta
1.30
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:FRES) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners